They suggested that CAFs recruit neutrophils that then released IL-6, which could induce neutrophil activation and PD-L1 expression; thus, the PD-L1+ activated neutrophils have a pro-tumor role through the IL6-STAT3-PD-L1 signaling pathway to inhibit T cell immunity. This evidence concerns the gene IL6 and neoplasm.